We found an increase in EGR3 protein expression in migrating tumour cells in the periphery, suggesting that EGR3 plays a role in tumour cell migration, thereby indirectly causing accelerated tumour progression, which leads to poor patient outcome. The gene discussed is EGR3; the disease is neoplasm.